reports
General Electric Co: 1 director
A director at General Electric Co sold 13,601 shares at 135.550USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
GE Vernova Acquires Greenbird to Accelerate GridOS® Innovation and Hel...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- GE Vernova’s Digital business today announced it has acquired Greenbird Integration Technology AS, a data integration platform company focused on utilities. This acquisition highlights GE Vernova’s commitment to investing in technologies and talent that help accelerate the sustainable energy grid. The platform will accelerate GridOS®, the world’s first software portfolio designed specifically for grid orchestration, adding new capabilities for connecting systems and integrating data across the grid more easily and at scale. The financial terms of the acquisi...
GE Digital Signs Collaboration Agreement with AWS to Help Utilities Ac...
SAN RAMON, Calif.--(BUSINESS WIRE)-- , an energy software leader, today announced that it has signed a multiyear strategic collaboration agreement with Amazon Web Services, Inc. (AWS) aimed at helping utilities accelerate grid modernization. Through this collaboration, GE Digital and AWS plan to deliver intelligent grid orchestration solutions. These software solutions will help utilities digitally transform, modernize the power grid, and accelerate the energy transition. GE Digital will deliver a new grid operating software platform, , and cloud-enabled solutions that are designed to be secu...
ELPEDISON Chooses GE Digital Software to Help Ensure Greece’s Access t...
SAN RAMON, Calif.--(BUSINESS WIRE)-- , an energy software leader, today announced that , the first independent energy producer in Greece, has chosen its cloud-based Asset Performance Management (APM) Reliability application to improve the reliability of its combined cycle fleet. The software will be installed at ELPEDISON’s Thisvi and Thessaloniki power plants, making it the first energy company in the country to cover an entire combined cycle plant with digital twin technology. helps reduce unplanned downtime by predicting equipment issues before they occur. The software provides asset-inte...
GE Healthcare and ulrich medical announce an Agreement to Offer a Bran...
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- GE Healthcare has today announced an agreement with ulrich medical for a GE Healthcare branded contrast media injector in the U.S. The CT motion multi-dose syringeless injector, which delivers iodinated contrast media for Computed Tomography (CT) imaging procedures, reduces procedure setup time and increases patient throughput by eliminating time consuming preparation steps, while helping to optimize patient dosing and reduce wasted contrast media. This press release features multimedia. View the full release here: GE Healthcare branded CT Motion injector ...
GE Healthcare Announces $80 Million Investment To Expand Contrast Medi...
SPANGEREID, Norway--(BUSINESS WIRE)-- GE Healthcare’s Pharmaceutical Diagnostics business announced an $80 million investment to increase manufacturing capacity by 30 percent at its Active Pharmaceutical Ingredients (API) site in Lindesnes, Norway. The investment – which is creating around 100 new jobs – is part of GE Healthcare’s broader commitment to address significant future global demand for iodinated contrast media, used in Xray and Computed Tomography (CT) procedures around the world to enhance visualization of organs, blood vessels and tissues across disease pathways. This press releas...
DATSCAN™ (Ioflupane I 123 Injection) indication expanded to include us...
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- GE Healthcare’s DaTscan has been approved by the U.S. Food and Drug Administration (FDA) for use in patients with suspected Dementia with Lewy Bodies (DLB). This new indication is in addition to its use with single photon emission computed tomography (SPECT) imaging to visualize dopamine transporters (DaT) in the brains of adult patients with suspected Parkinsonian syndromes. With the expanded indication, DaTscan is now available to more patients, including those with suspected DLB, in the United States. The clinical signs and symptoms of DLB can be atypi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.